Alessandro Passardi

Trials

Studies that name Alessandro Passardi as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:12 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT06522919 · Sequential Immunochemotherapy Treatment with Pembrolizumab Plus Dendritic Cell (DC) Vaccine Followed by Trifluridine/Tipiracil Plus Bevacizumab in Refractory Mismatch-repair-proficient (pMMR) or Microsatellite-stable (MSS) Metastatic Colorectal Cancer

  Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · recruiting · Colorectal Cancer Metastatic, Microsatellite Stable Colorectal Carcinoma, Refractory Mismatch-repair-proficient (pMMR) Metastatic Colorectal Cancer · principal investigator
• N/A
  NCT04826458 · Clinical Study Comparing Different Strategies to Increase Adherence to Oral Therapies in Oncohematology

  Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · completed · Cancer, Solid Tumor, Hematologic Malignancy · study chair
• N/A
  NCT04680104 · Prospective Observational Study Comparing Calcium and Sodium Levofolinate in Combination With 5-Fluorouracil (5FU) /or in FOLFIRI Regimen

  Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · completed · Gastrointestinal Cancer, CALCIUM LEVOFOLINATO (Ca-lev), SODIUM LEVOFOLINATO (Na-lev) · principal investigator
• N/A
  NCT02921724 · Participatory Research for Fine-tuning of a 2.0 System to Optimise Home Management of Oral Cancer Therapies.

  Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · unknown · Cancer, Oral Drug Administration · study chair
• N/A
  NCT02645357 · Implementing an Evidence-based Computerized Decision Support System Linked to Electronic Health Records to Improve Care for Cancer Patients

  Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · completed · Medical Oncology · principal investigator
• Ph2
  NCT02000050 · Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carcinoma (COLORE)

  Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · completed · Rectal Carcinoma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:12 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.